v0.39.16

Current - 4 hours ago

Grey lines are ignored Blue lines are triggers
* Home
* Insights
* Team
* Portfolio
Select Page
Investing in the future of healthcare.
Zoic Capital is a US-based venture firm focused on early stage healthcare innovations at the intersection of life sciences and medical technology.
Apply for funding
Insights:
Commercialization Overview
Jun 2, 2022 | Research Report
Stay Ahead of MedTech Investing with Zoic Research Reports: Fill out the form to download this report. Commercialization is the process of taking a product or innovation and making it available for public use. To be successful, a company must have a positive...
Intellectual Property Deep Dive
Jun 2, 2022 | Research Report
Stay Ahead of MedTech Investing with Zoic Research Reports: Fill out the form to download this report. Zoic Capital focuses on investing in companies with strong Intellectual Property (IP). IP for startups has some unique considerations, including the need for a great...
Problem To Solution Primer
Jun 2, 2022 | Research Report
Stay Ahead of MedTech Investing with Zoic Research Reports: Fill out the form to download this report. Innovation happens when someone identifies a problem and then finds a way to address it. We become accustomed to the way that our world works, and we stop being...
Regulatory Deep Dive
Jun 1, 2022 | Research Report
Stay Ahead of MedTech Investing with Zoic Research Reports: Fill out the form to download this report. The FDA has two approval pathways for medical devices and drugs, depending on the product. A combination product is a mix of two or more regulated components that...
The Future of MedTech: Brain-Computer Interfaces (BCI)
May 19, 2022 | Research Report
Stay Ahead of MedTech Investing with Zoic Research Reports: Zoic Capital is releasing a series of research reports across the MedTech spectrum. We’re doing this to: Help investors better understand the landscape, Grasp the opportunities that exist now and may exist in...
Evolving Landscape of Immigration Policy: Guest Tahmina Watson
May 18, 2022 | Podcast
In this episode of Market Meditations, Chris and Neal welcome guest Tahmina Watson onto the show. Join us as we discuss the evolving landscape of immigration policy and how Tahmina is helping others navigate the changes in presidential administrations as well as the...
Zoic Capital Adds Shayan Bhattacharyya, Venture Partner
Apr 5, 2022 | News
Zoic Capital, an early-stage venture capital firm focused on medical technology, has added MedTech and Payer industry veteran Shayan Bhattacharyya to the team as Venture Partner. Shayan has deep expertise across the healthcare ecosystem and works with MedTech...
Neuralink and the Long Path to Approval
Sep 11, 2021 | Blog
DEALFLOWUPDATE Issue #64. Friday, September 11Hello Everyone,For the edition of the Zoic newsletter, we will be looking at a variety of topics, spanning from food allergies to gene therapy to a review of data and IP as well as an update on COVID-19 vaccine progress....
At The Human Edge: The Limits Of Human Physiology And Performance: Guest Dr. Marcus Ranney
Jun 7, 2021 | Podcast
Chris and Neal invite special guest Dr. Marcus Ranney onto the show to discuss his new book, At The Human Edge, as well as his work on the front lines of the COVID-19 pandemic in India. The book is a non-fiction-based piece of popular science which unravels the...
Zoic Capital Portfolio Company JunoDx Closes $25M Series A
Jun 4, 2021 | News
- Funds will enable launch of prenatal noninvasive genetic testing Seattle, WA – June 4, 2021 – Zoic Capital, a venture firm focused on early-stage medical technology investments, announced that portfolio company Juno Diagnostics has closed its $25M Series A...
« Older Entries
Quick Links:
FOUNDER?
Apply for funding
INVESTOR?
Request Invite
Join Zoic's Newsletter
Our team of industry experts and professionals provide industry news, guidance and perspective within the life sciences and medtech investment sectors. To see the type of deals and company innovation we pay attention to, consider receiving our biweekly deal flow newsletter.
Email Address
Subscribe
113 Cherry St.
PMB 29813
Seattle, WA 98104-2205
© 2020 All Right Reserved Zoic Capital
* Home
* Insights
* Portfolio
* Team
* Blog
* News
* Podcast
* Research Report
* Apply for Funding
* Co-Investment Program
* Follow
* Follow
For now, Differences are performed on text, not graphically, only the latest screenshot is available.

Screenshot requires Playwright/WebDriver enabled